$FOLD Headlines Apple sets intraday record; Pe
Post# of 72711
Posted On: 11/10/2014 12:15:53 PM
$FOLD Headlines
Apple sets intraday record; PetSmart considers sale 12:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 7:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 7:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 4:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 8:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 6:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 6:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 9:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 9:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 7:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 5:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 8:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 7:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 6:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 5:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 4:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 6:28 a.m. July 18, 2012 - MarketWatch.com
U.S. may end patents on DNA: report 12:13 p.m. Oct. 30, 2010 - Christopher Hinton
Monday's biggest gaining and declining stocks 3:51 p.m. Oct. 5, 2009 - MarketWatch
Amicus Therapeutics' (FOLD) CEO John Crowley on Q3 2014 Results - Earnings Call Transcript 9:50 a.m. Nov. 9, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:18 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
InsiderInsights.com Daily Round Up 10/28/14: POL, NHF, SLB, ATI 6:58 a.m. Oct. 29, 2014 - Seeking Alpha
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Genervon ALS drug shows encouraging results 8:27 a.m. Oct. 20, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/6/14: IVAC, OPK, AVNW, CNBKA 10:45 a.m. Oct. 7, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus 1:25 p.m. Sept. 8, 2014 - benzinga.com
Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape 8:36 a.m. Sept. 3, 2014 - Zacks.com
InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical 10:13 a.m. Aug. 30, 2014 - Seeking Alpha
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog 9:49 a.m. Aug. 27, 2014 - Zacks.com
The Biotech Stock With The Best One-Week Performance 2:46 p.m. Aug. 25, 2014 - benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog 4:55 p.m. Aug. 21, 2014 - Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD) 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape 9:39 a.m. Aug. 21, 2014 - Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape 9:03 a.m. Aug. 21, 2014 - Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript) 3:43 p.m. Aug. 20, 2014 - Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:15 a.m. Aug. 20, 2014 - benzinga.com
Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Nov. 6, 2014 - GlobeNewswire
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 7:45 a.m. Oct. 22, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011 6:00 p.m. Oct. 19, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable 8:30 a.m. Sept. 30, 2014 - GlobeNewswire
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 7:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 5:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 3:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 7:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 1:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 5:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 6:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 7:20 a.m. June 4, 2014 - PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference 3:10 p.m. May 14, 2014 - GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. May 5, 2014 - GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive Conference 9:30 a.m. May 5, 2014 - BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 7:00 a.m. May 2, 2014 - PR Newswire - PRF
Apple sets intraday record; PetSmart considers sale 12:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 7:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 7:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 4:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 8:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 6:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 6:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 9:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 9:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 7:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 5:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 8:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 7:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 6:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 5:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 4:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 6:28 a.m. July 18, 2012 - MarketWatch.com
U.S. may end patents on DNA: report 12:13 p.m. Oct. 30, 2010 - Christopher Hinton
Monday's biggest gaining and declining stocks 3:51 p.m. Oct. 5, 2009 - MarketWatch
Amicus Therapeutics' (FOLD) CEO John Crowley on Q3 2014 Results - Earnings Call Transcript 9:50 a.m. Nov. 9, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:18 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
InsiderInsights.com Daily Round Up 10/28/14: POL, NHF, SLB, ATI 6:58 a.m. Oct. 29, 2014 - Seeking Alpha
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Genervon ALS drug shows encouraging results 8:27 a.m. Oct. 20, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/6/14: IVAC, OPK, AVNW, CNBKA 10:45 a.m. Oct. 7, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus 1:25 p.m. Sept. 8, 2014 - benzinga.com
Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape 8:36 a.m. Sept. 3, 2014 - Zacks.com
InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical 10:13 a.m. Aug. 30, 2014 - Seeking Alpha
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog 9:49 a.m. Aug. 27, 2014 - Zacks.com
The Biotech Stock With The Best One-Week Performance 2:46 p.m. Aug. 25, 2014 - benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog 4:55 p.m. Aug. 21, 2014 - Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD) 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape 9:39 a.m. Aug. 21, 2014 - Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape 9:03 a.m. Aug. 21, 2014 - Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript) 3:43 p.m. Aug. 20, 2014 - Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:15 a.m. Aug. 20, 2014 - benzinga.com
Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Nov. 6, 2014 - GlobeNewswire
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 7:45 a.m. Oct. 22, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011 6:00 p.m. Oct. 19, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable 8:30 a.m. Sept. 30, 2014 - GlobeNewswire
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 7:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 5:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 3:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 7:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 1:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 5:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 6:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 7:20 a.m. June 4, 2014 - PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference 3:10 p.m. May 14, 2014 - GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. May 5, 2014 - GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive Conference 9:30 a.m. May 5, 2014 - BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 7:00 a.m. May 2, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼